胃癌;法舒地尔;迁移;侵袭;基质金属蛋白酶;血管内皮生长因子

," /> 胃癌;法舒地尔;迁移;侵袭;基质金属蛋白酶;血管内皮生长因子

,"/> Gastric cancerFasudilMigrationInvasionMatrix metalloproteinases MMP);Vascular endothelial growth factor VEGF,"/>  <span style="font-family:宋体;">Effect of Fasudil on proliferation, invasion and metastasis of gastric cancer MGC-803 cells</span>

Chinese Clinical Oncology ›› 2018, Vol. 23 ›› Issue (10): 875-880.

Previous Articles     Next Articles

 Effect of Fasudil on proliferation, invasion and metastasis of gastric cancer MGC-803 cells

  

  1. Department of Faculty of Pharmaceutical Sciences the Seventh Peoples Hospital of Zhengzhou Zhengzhou 450000
  • Received:2018-02-23 Revised:2018-07-07 Online:2018-10-31 Published:2019-03-20

Abstract:  

Objective  To investigate the effect of Fasudil on the pfoliferation invasion and migration of gastric cancer MGC-803 cells and their probable mechanisms. Methods  MGC-803 cells were treated with different concentration of Fasudil and cell number was counted. And the subsequent experiments were conducted in 3 groups respectively contained 10 25 50 μmolL of Fasudil, the MGC-803 cells treated with Fasudil were taken as the treatment group while those not treated with Fasudil were taken as the control group. The cells were cultured for 4 days0 24 48 72 96 h), and the cell growth folds were detected by CCK-8.The ability of cell migration was detected by wound-healing assay. The ability of cell invasion was detected by Transwell. The protein expression levels of vascular endothelial growth factor VEGF), matrix metalloproteinases 9MMP-9), matrix metalloproteinases14 MMP-14 and epithelial mesenchymal transformation EMT markers Vimentin and E-cadherin were detected by Western blotting. Results  The toxicity test showed that Fasudil inhibited the cell growth of MGC-803 cells in a dose-dependent manner and the cell growth folds were reduced in the treatment group. There was an obvious decrease in the growth folds compared to the control group P0.01. The results of wound healing assay showed that the wound closure rate in the treatment group was lower than that of the control group and in a dose-dependent mannerP0.01. Transwell results showed that the number of invasive cells in the treatment group was decreased significantly compared with the control group P0.01. Besides Fasudil significantly decreased the expression levels of VEGF MMP-9 MMP-14 and Vimentin and up-regulated the expression levels of E-cadherin. Conclusion  Fasudil may inhibit cell proliferation migration and invasion of MGC-803 cells reduce the activity of MMP-9 MMP-14 and VEGF which will provide new sight and theoretical basis for the treatment of gastric cancer.

Key words: font-family:宋体, Gastric cancer">Gastric cancerfont-family:宋体, FasudilMigrationInvasionMatrix metalloproteinases MMP);Vascular endothelial growth factor VEGF)')">">;FasudilMigrationInvasionMatrix metalloproteinases MMP);Vascular endothelial growth factor VEGF

CLC Number: 

  • R735.2
[1] Department of Gastroenterology, Central Hospital Affiliated to Shenyang Medical College, Shenyang , China.

Effect of mithramycin on cell cycle and apoptosis of gastric cancer cells and its possible mechanism [J]. Chinese Clinical Oncology, 2019, 24(2): 133-136.

[2] NIU Hong, TIAN Tongde, TANG Jingwen, YUE Guangxing, LI Huahua, FAN Yixiao, ZHOU Haoben..

Targeted regulation of MAP3K9 expression by microRNA-148a-3p and its effect on proliferation and apoptosis of gastric cancer cells [J]. Chinese Clinical Oncology, 2019, 24(2): 108-112.

[3] HE Jiajie, LI Min, TANG Guofu, LI Houze, QI Xiaolong..

Effects of isocryptotanshinone on proliferation, cycle and apoptosis of gastric cancer cells [J]. Chinese Clinical Oncology, 2019, 24(2): 129-132.

[4] GU Yongjuan, CHEN Yanan.. Relationship between the expressions of PI3K, Akt, Survivin and clinicopathologic parameters and prognosis in patients with gastric cancer [J]. Chinese Clinical Oncology, 2018, 23(5): 413-418.
[5] YU Jinyou, QIU Jianling, ZHU Zhengfeng, TIAN Cuifang.. Expression and clinical significance of miR-98 and miR-183 in gastric cancer [J]. Chinese Clinical Oncology, 2018, 23(5): 408-412.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!